Posted: April 27th, 2018
Austrian Court of Appeals confirms PI based on equivalent infringement of Eli Lilly’s Alimta®-Patent In a decision of April 12th 2018, the Vienna Court of Appeals rejected an appeal against a preliminary injunction previously granted by the Vienna Commercial Court. The Court of Appeals confirmed that the offer or sale of a generic Pemetrexed product […]
READ MOREPosted: March 2nd, 2018
Sandoz A/S v. ViiV Healthcare UK Limited, Patent and Market Court of Appeal, Sweden, 30 June 2017, Docket No. PMÖ 3565-17 Sandoz requested that the preliminary injunction barring its pharmaceutical products Abacavir/Limavudine Sandoz 600 mg/300 mg from being marketed and sold on the Swedish market be vacated. The Patent and Market Court of Appeal overturned […]
READ MOREPosted: February 7th, 2018
Gilead Biopharmaceutics Ireland UC., Gilead Sciences, S.L.U., Gilead Sciences Ireland UC., Gilead Sciences, Inc. v. Teva Pharma, S.L.U, Mylan Pharmaceuticals, S.L., Mylan S.A.S., Barcelona Commercial Court No. 4, 20 October 2017, Docket No. 190/2017 – 197/17 In its decision of 20 October 2017, Barcelona Commercial Court No. 4 reversed its previous rulings pursuant to which […]
READ MOREPosted: November 2nd, 2017
Sandoz B.V. v. Astrazeneca AB, Court of Appeal The Hague, The Netherlands, 31 October 2017, Case No. 200.200.332/01, with thanks to Willem Hoyng and Theo Blomme, HOYNG ROKH MONEGIER, for submitting the case including an English and German translation thereof Astrazeneca markets FASLODEX which is used for the treatment of oestrogen hormone dependent breast cancers. […]
READ MOREPosted: October 16th, 2017
Shionogi Sieyaku Kabushiki Kaisha, AstraZeneca UK Limited, AstraZeneca Farmacéutica Spain, S.A. v. Ratiopharm España, S.A., Barcelona Commercial Court No. 5, 12 July 2017, Docket No. 148/2017 In a decision rendered on 12 July 2017, Commercial Court No. 5 of Barcelona overruled its previous order of 21 February 2017, pursuant to which it granted ex parte […]
READ MOREPosted: September 25th, 2017
Allergan, Inc. v. Orifarm A/S, Preliminary Relief Judge District Court of The Hague, the Netherlands, 15 September 2017, Case number ECLI:NL:RBDHA:2017:10574 Allergan is the holder of the European patent EP 1 658 858 B2 entitled “Use of botulinum toxin for the treatment of recalcitrant voiding dysfunction”. The patent was filed on 15 July 1998 relying […]
READ MOREPosted: August 30th, 2017
Ruby Decor B.V. and Aparto B.V. v. Basic Holdings ULC, Court of Appeal The Hague, 22 August 2017, Case No. ECLI:NL:GHDHA:2017:2409, with thanks to Alexander Tsoutsanis, DLA Piper, for sending in the judgment as well as an English translation thereof Artificial fireplaces. Earlier, the Judge in PI proceedings ruled that in his preliminary opinion Ruby Decor did […]
READ MOREPosted: July 31st, 2017
Mobile Sanitary Solutions B.V. v. TWT Verhuur B.V., Summary Judge of the District Court of The Hague, 28 July 2017, Case No. ECLI:NL:RBDHA:2017:8486 Patent Holder Mobile Sanitary Solutions alleges infringement. TWT states that the patent invoked is invalid. In a preliminary ruling the summary judge agrees with TWT and holds that the patent is likely […]
READ MOREPosted: June 9th, 2017
Carl Zeiss Meditec AG v. VSY Biotechnology B.V. et al., District Court The Hague, The Netherlands, 7 June 2017, Case No. ECLI:NL:RBDHA:2017:6136 European Patent on an intraocular (implantable) lens. Interpretation of claims. The Dutch part of the patent is valid: the hurdles of novelty, inventive step and enablement were all taken successfully. The patent is […]
READ MORE
EMAIL US
